Initializing
Investing at the frontier of applied intelligence, human resilience, and sovereign defense backing founders building the future
Companies turning raw intelligence into measurable outcomes — autonomous systems, decision engines, and AI-native workflows reshaping industries at scale.
The convergence of compute and biology unlocking new paradigms in diagnostics, drug discovery, and precision therapeutics at molecular scale.
Care Shift Podcast →Next-generation defense platforms, cybersecurity infrastructure, and dual-use technologies safeguarding democratic societies against emerging threats.
We bring conviction, operational DNA, and sector-specific networks that compound over decades.
We spend months mapping markets before writing checks. When we invest, it's because we've developed an independent thesis on why this team wins this market now.
Our partners have built and scaled companies across defense, biotech, and enterprise software. Pattern recognition from the arena, not the sidelines.
Beyond capital, we unlock government procurement pathways, clinical trial partnerships, and Fortune 100 distribution channels unique to our sectors.
The companies reshaping civilization need patient, committed capital. We structure our funds for decade-long partnerships through every inflection point.
We respond to every founder who reaches out. Tell us what you're building and why now.
Submit your deck